It was found recently that 4-aminopyridine (4AP) potentiated the amplitude of endplate potentials (EPPs) in a dose-dependent manner with concomitant increase in the fractional release (P). The presence of typical pharmacological dose-release relation of 4AP suggested that P obtained from the above simple kinetic analysis is a useful parameter in studying the mode of action of chemical release modulators such as 4AP a:nd streptomycin (SM).11) Thus, it was found that heterocyclic and aromatic diamines strongly accelerated and alicyclic diamines inversely depressed the early tetanic rundown. This was interpreted to mean that these chemicals modify the excitation-secretion coupling of motor nerve terminal via combination with a certain receptive site in the hypothetical Ca-sensitive component X. This component X has been treated as a single entity since its nature still remain in a state of black box. SM antagonizes the 4AP effect by competing for the occupancy of receptive site in the component X.
Tetraethylammonium (TEA)6)'7)'9) and guanidine (G)3),9),14) have been reported to augment enormously the evoked release of transmitter as do 4AP7)'9),11) and 3,4-diaminopyridine (34DAP).13) All these compounds generate the giant EPPs in tetrodotoxin-treated muscles4>'3 "° and the chemicals also restore neuromuscular transmission in Botulinum toxin-treated preparations.9),13) Further, statistical analysis showed that the effects of the compounds on the presynaptic release parameters are due entirely to a marked increase in the number of immediately available quanta.
The probability of release remains unaltered.2),s),1~),15) If 4AP, 34DAP, G and TEA all affect a single site or process in the complex chain of events underlying transmitter release, there would be a certain common mode of action among these agents. Therefore, the modes of the facilitatory presynaptic actions of 4AP, G, o-phenylenediamine (PDA) and TEA were studied in the present paper on the curarized frog sciatic nerve-sartorius muscle preparations by calculating Ps from the intracellularly recorded EPPs elicited with short train stimulation.ll)
As shown in Fig. 1A TEA with the Ca-bound X to from G2 • Ca4X and TEA2. Ca4X, respectively. As shown in Fig. 1B , the slope of Hill plots for PDA and 4AP were almost unity (1.0 and 1.1) whereas those for TEA and G were close to two (1.6 and 1.9). When the release parameters graphically estimated from Fig. lB are applied to the hypothetical nth power equation for the accelerated evoked release, the calculated dose-release curves are found to fit reasonably well the data (Fig. 1A) .
4AP and TEA are potent blockers of K channels in the excitable membrane, and therefore prolong the nerve terminal action potential. Accordingly, the usual explanation for the actions of these drugs on transmitter release is an increase in Ca influx due to the prolongation of the terminal spike potential.'
In fact, the second positive phase of the terminal action potential is abolished almost completely in 4AP and TEA. On the contrary, only slight alteration in the wave form of the second positive phase can be detected either with 10 mM G, 10 mM PDA, 1 mM neomycin (NM) or 5 mM SM (Fig. 2) , although the drugs at these concentrations exert distinct presynaptic effects on the neuromuscular transmission. All the records were computer-averages of 16 sweeps for 4AP and TEA, 120 sweeps for G, and 64 sweeps for PDA, NM and SM (clock: 5 psec). 1, 2, and 3 in the records of 4AP and TEA designate recordings of the 1st, 2nd and 3rd action potentials in a triple pulse stimulation of 5 Hz, respectively. Interval between train stimulations was 30 sec. Nerve was stimulated continuously at 0.5 Hz in the other records.
Ca concentration was reduced to 0.9 mM. In the control records, positive-negative-positive going triphasic spike potential is followed by a slower negative deflection which corresponds to the endplate current.
Note that the second positive phase of the terminal action potential was abolished only with 4AP and TEA. Voltage calibration is 50pV for 4AP and TEA, 1 mV for G, and 0.1 mV for the rest of records.
Time scales are 1 msec. [Vol. 58(B) ,
It should be noted in the case of TEA that the characteristics of terminal action potential were apt to vary during successive nerve stimulations.
The first action potential was slightly larger in amplitude and conducted somewhat slower than that of the control, whereas the second and third ones were considerably smaller but arrived significantly earlier (Fig. 2) . On the other hand, the wave form of terminal action potential was relatively constant in control and 4AP Ringers.
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